Bi-weekly docetaxel and gemcitabine regimen in her-2-negative and anthracycline-pretreated metastatic breast cancer patients: a multicenter phase II trial
暂无分享，去创建一个
A. Ballestrero | M. Mencoboni | F. Brema | R. Murialdo | U. Folco | F. Bertolotti | L. Canobbio | M. Parodi | F. Vaira | C. Simoni | M. Bergaglio | G. Pastorino | N. Cinzia